Shanghai Haohai Biological Technology Co., Ltd.

DB:5HB Stock Report

Market Cap: €1.7b

Shanghai Haohai Biological Technology Valuation

Is 5HB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 5HB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 5HB (€3.3) is trading below our estimate of fair value (€15.75)

Significantly Below Fair Value: 5HB is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 5HB?

Key metric: As 5HB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 5HB. This is calculated by dividing 5HB's market cap by their current earnings.
What is 5HB's PE Ratio?
PE Ratio13.8x
EarningsCN¥430.21m
Market CapCN¥13.03b

Price to Earnings Ratio vs Peers

How does 5HB's PE Ratio compare to its peers?

The above table shows the PE ratio for 5HB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average15.9x
BIO3 Biotest
15.4x29.3%€1.3b
FYB Formycon
13.8x32.4%€882.8m
2INV 2invest
12.8xn/a€64.4m
DMP Dermapharm Holding
21.6x18.1%€2.0b
5HB Shanghai Haohai Biological Technology
13.8x16.8%€14.0b

Price-To-Earnings vs Peers: 5HB is good value based on its Price-To-Earnings Ratio (13.8x) compared to the peer average (15.9x).


Price to Earnings Ratio vs Industry

How does 5HB's PE Ratio compare vs other companies in the European Biotechs Industry?

5 CompaniesPrice / EarningsEstimated GrowthMarket Cap
5HB 13.8xIndustry Avg. 27.6xNo. of Companies5PE020406080100+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 5HB is good value based on its Price-To-Earnings Ratio (13.8x) compared to the European Biotechs industry average (26.5x).


Price to Earnings Ratio vs Fair Ratio

What is 5HB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

5HB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.8x
Fair PE Ratio16.5x

Price-To-Earnings vs Fair Ratio: 5HB is good value based on its Price-To-Earnings Ratio (13.8x) compared to the estimated Fair Price-To-Earnings Ratio (16.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies